Molecular Imaging, Inc. Featured in May 15th Genetic Engineering & Biotechnology News

May 21, 2012
Genetic Engineering & Biotechnology News delves into the changes in CROs to meet the evolving needs of their clients in the May 15th article, “CRO Capabilities Expand to Suit Client Needs”. The growing reliance on imaging prompted a discussion with Patrick McConville, Ph.D., co-founder and CSO, Molecular Imaging (MI).

According to Dr. McConville, MII uses a full range of imaging modalities for anatomical, functional, and molecular outputs, enabling the company to provide their customers with combined pharmacology and imaging biomarkers that assist in their go/no-go decision-making process. The increasing reliance on imaging in the pharmaceutical industry as well as parallel improvements in the technology has enabled MI to add a broad base of imaging assays.

Read the full article at http://www.genengnews.com/gen-articles/cro-capabilities-expand-to-suit-client-needs/4113/